Journal issue overview 7/2013 Internal Medicine

546

Liver disorders in diabetic patients

R. Brůha, K. Dvořák, J. Petrtýl

551

Effects of GLP-1 (glucagon‑like peptide‑ 1) on liver

J. Fontana, Z. Červinková, M. Anděl

559

Digestive tract polyposes

V. Jirásek

566

Neonatal hyperbilirubinemia and molecular mechanisms of jaundice

M. Jirsa, E. Sticová

572

Cystic tumors of the pancreas – our experience with diagnostics

T. Krechler, J. Ulrych, M. Dvořák, D. Hoskovec, J. Macášek, T. Švestka, J. Hořejš

578

Wilson’s disease

Z. Mareček, R. Brůha

584

Effect of liver cirrhosis on pharmacokinetics and pharmacodynamics of drugs

F. Perlík

587

Hepatic cein catheterisation – selected assessment aspects

J. Petrtýl, R. Brůha, P. Urbánek, Z. Mareček, M. Kaláb

591

Reactivation of chronic hepatitis B

J. Šperl

597

Acute pancreatitis – new developments in treatment

J. Špičák

606

Hepatic involvement in patients with non‑Hodgkin’s lymphoma

M. Trněný, J. Šálková, J. Dlouhá, J. Stříteský

612

Treatment of chronic hepatitis C virus infection at the beginning of a new era

P. Urbánek

618

Relationship of bilirubin to diseases caused by increased oxidative stress

L. Vítek

624

Tyrosine kinase inhibitors – major change in the prognosis of chronic myeloid leukaemia

H. Klamová

627

Multiple myeloma

I. Špička, M. Klánová

632

Advances in the treatment of chronic lymphocytic leukaemia

P. Obrtlíková, M. Trněný

635

Myelodysplastic syndromes – therapy progress over the last two decades

A. Jonášová

Internal Medicine - Issue 7/2013

Internal Medicine